| Year |
Citation |
Score |
| 2014 |
Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, del Prete GQ, Hill BJ, Timmer JK, Reiss E, Yarden G, Darko S, ... ... Langer JA, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature. 511: 601-5. PMID 25043006 DOI: 10.1038/Nature13554 |
0.327 |
|
| 2014 |
Lasfar A, Cook JR, Cohen Solal KA, Reuhl K, Kotenko SV, Langer JA, Laskin DL. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Immunology. 142: 442-52. PMID 24597649 DOI: 10.1111/Imm.12273 |
0.451 |
|
| 2013 |
Sandler NG, Zhu RT, Estes JD, Boritz E, Rao S, Lifson JD, Levin D, Schreiber G, Langer JA, Douek DC. 223 Cytokine. 63: 296. DOI: 10.1016/J.Cyto.2013.06.226 |
0.381 |
|
| 2008 |
Pan M, Kalie E, Scaglione BJ, Raveche ES, Schreiber G, Langer JA. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists. Biochemistry. 47: 12018-27. PMID 18937499 DOI: 10.1021/Bi801588G |
0.534 |
|
| 2007 |
Langer JA. Interferon at 50: new molecules, new potential, new (and old) questions. Science's Stke : Signal Transduction Knowledge Environment. 2007: pe53. PMID 17895481 DOI: 10.1126/Stke.4052007Pe53 |
0.486 |
|
| 2004 |
Kotenko SV, Langer JA. Full house: 12 receptors for 27 cytokines. International Immunopharmacology. 4: 593-608. PMID 15120645 DOI: 10.1016/J.Intimp.2004.01.003 |
0.404 |
|
| 2004 |
Langer JA, Cutrone EC, Kotenko S. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine & Growth Factor Reviews. 15: 33-48. PMID 14746812 DOI: 10.1016/J.Cytogfr.2003.10.001 |
0.723 |
|
| 2003 |
Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunology. 4: 69-77. PMID 12483210 DOI: 10.1038/Ni875 |
0.493 |
|
| 2001 |
Cutrone EC, Langer JA. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding. The Journal of Biological Chemistry. 276: 17140-8. PMID 11278538 DOI: 10.1074/Jbc.M009663200 |
0.767 |
|
| 1999 |
Goldman LA, Zafari M, Cutrone EC, Dang A, Brickelmeier M, Runkel L, Benjamin CD, Ling LE, Langer JA. Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 19: 15-26. PMID 10048764 DOI: 10.1089/107999099314379 |
0.73 |
|
| 1998 |
Goldman LA, Cutrone EC, Dang A, Hao X, Lim JK, Langer JA. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras. Biochemistry. 37: 13003-10. PMID 9737881 DOI: 10.1021/Bi980073J |
0.769 |
|
| 1998 |
Langer JA, Yang J, Carmillo P, Ling LE. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons. Febs Letters. 421: 131-5. PMID 9468293 DOI: 10.1016/S0014-5793(97)01550-0 |
0.599 |
|
| 1997 |
Lundgren E, Langer JA. Nomenclature of interferon receptors and interferon-delta. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 17: 431-2. PMID 9243377 DOI: 10.1089/Jir.1997.17.431 |
0.424 |
|
| 1997 |
Cutrone EC, Langer JA. Contributions of cloned type I interferon receptor subunits to differential ligand binding. Febs Letters. 404: 197-202. PMID 9119063 DOI: 10.1016/S0014-5793(97)00129-4 |
0.767 |
|
| 1996 |
Goldman LA, Cutrone EC, Kotenko SV, Krause CD, Langer JA. Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques. 21: 1013-5. PMID 8969825 DOI: 10.2144/96216Bm10 |
0.665 |
|
| 1994 |
Lim JK, Xiong J, Carrasco N, Langer JA. Intrinsic ligand binding properties of the human and bovine alpha-interferon receptors. Febs Letters. 350: 281-6. PMID 8070579 DOI: 10.1016/0014-5793(94)00787-X |
0.458 |
|
| 1994 |
Langer JA, Rashidbaigi A, Garotta G, Kempner E. Radiation inactivation of human gamma-interferon: cellular activation requires two dimers. Proceedings of the National Academy of Sciences of the United States of America. 91: 5818-22. PMID 8016072 DOI: 10.1073/Pnas.91.13.5818 |
0.509 |
|
| 1993 |
Lim JK, Langer JA. Cloning and characterization of a bovine alpha interferon receptor. Biochimica Et Biophysica Acta. 1173: 314-9. PMID 8318540 DOI: 10.1016/0167-4781(93)90129-2 |
0.434 |
|
| 1993 |
Lim JK, Langer JA. Generation and characterization of anti-idiotypic antibodies recognizing the interferon-alpha receptor: implications for ligand-receptor interactions. Journal of Interferon Research. 13: 295-301. PMID 7693831 DOI: 10.1089/Jir.1993.13.295 |
0.513 |
|
| 1992 |
Langer JA, Puvanakrishnan R, Womack JE. Somatic cell mapping of the bovine interferon-alpha receptor. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 3: 237-40. PMID 1535250 DOI: 10.1007/Bf00355725 |
0.503 |
|
| 1990 |
Puvanakrishnan R, Langer JA. Detection and analysis of interferon-alpha receptors on plasma membranes and in detergent extracts. Journal of Interferon Research. 10: 299-307. PMID 2143524 DOI: 10.1089/Jir.1990.10.299 |
0.455 |
|
| 1990 |
Langer JA, Rashidbaigi A, Lai LW, Patterson D, Jones C. Sublocalization on chromosome 21 of human interferon-alpha receptor gene and the gene for an interferon-gamma response protein. Somatic Cell and Molecular Genetics. 16: 231-40. PMID 2141727 DOI: 10.1007/Bf01233359 |
0.479 |
|
| 1989 |
Li BL, Langer JA, Schwartz B, Pestka S. Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha. Proceedings of the National Academy of Sciences of the United States of America. 86: 558-62. PMID 2911594 DOI: 10.1073/Pnas.86.2.558 |
0.435 |
|
| 1989 |
Zhao XX, Li BL, Langer JA, Van Riper G, Pestka S. Construction and phosphorylation of a fusion protein Hu-IFN-alpha A/gamma. Analytical Biochemistry. 178: 342-7. PMID 2502045 DOI: 10.1016/0003-2697(89)90650-7 |
0.491 |
|
| 1988 |
Langer JA. Radiolabeling of the interferon-alpha receptor. Biochemical and Biophysical Research Communications. 157: 1264-70. PMID 2974697 DOI: 10.1016/S0006-291X(88)81011-8 |
0.478 |
|
| 1988 |
Rashidbaigi A, Stefanos S, Jung V, Langer JA. Immune interferon receptor: chemical and enzymatic sensitivity. Journal of Interferon Research. 8: 641-54. PMID 2466913 DOI: 10.1089/Jir.1988.8.641 |
0.499 |
|
| 1986 |
Langer JA, Pestka S. Procedure for reduction and reoxidation of human leukocyte interferon. Methods in Enzymology. 119: 248-55. PMID 3762403 DOI: 10.1016/0076-6879(86)19036-7 |
0.322 |
|
| 1986 |
Langer JA, Lake JA. Elongation factor Tu localized on the exterior surface of the small ribosomal subunit. Journal of Molecular Biology. 187: 617-21. PMID 3712437 DOI: 10.1016/0022-2836(86)90339-6 |
0.323 |
|
| 1986 |
Langer JA, Ortaldo JR, Pestka S. Binding of human alpha-interferons to natural killer cells. Journal of Interferon Research. 6: 97-105. PMID 2941494 DOI: 10.1089/Jir.1986.6.97 |
0.482 |
|
| 1986 |
Rashidbaigi A, Langer JA, Jung V, Jones C, Morse HG, Tischfield JA, Trill JJ, Kung HF, Pestka S. The gene for the human immune interferon receptor is located on chromosome 6. Proceedings of the National Academy of Sciences of the United States of America. 83: 384-8. PMID 2934742 DOI: 10.1073/Pnas.83.2.384 |
0.473 |
|
| 1986 |
Langer JA, Pestka S. Procedures for studying binding of interferon to human cells in suspension cultures. Methods in Enzymology. 119: 305-11. PMID 2429148 DOI: 10.1016/0076-6879(86)19046-X |
0.371 |
|
| 1985 |
Langer JA, Pestka S. Changes in binding of alpha interferon IFN-alpha A to HL-60 cells during myeloid differentiation. Journal of Interferon Research. 5: 637-49. PMID 3866800 DOI: 10.1089/Jir.1985.5.637 |
0.496 |
|
| 1985 |
Greiner JW, Schlom J, Pestka S, Langer JA, Giacomini P, Kusama M, Ferrone S, Fisher PB. Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons. Pharmacology & Therapeutics. 31: 209-36. PMID 3843352 DOI: 10.1016/0163-7258(85)90023-3 |
0.315 |
|
| 1985 |
Greiner JW, Tobi M, Fisher PB, Langer JA, Pestka S. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression. International Journal of Cancer. Journal International Du Cancer. 36: 159-66. PMID 3160671 DOI: 10.1002/ijc.2910360206 |
0.343 |
|
| 1984 |
Langer JA, Jurnak F, Lake JA. Elongation factor Tu ternary complex binds to small ribosomal subunits in a functionally active state. Biochemistry. 23: 6171-8. PMID 6395891 DOI: 10.1021/Bi00320A043 |
0.345 |
|
| 1984 |
Langer JA, Pestka S. Purification, Bacterial Expression, and Biological Activities of the Human Interferons Journal of Investigative Dermatology. 83: S128-S136. DOI: 10.1038/Jid.1984.34 |
0.424 |
|
| 1983 |
Pestka S, Kelder B, Langer JA, Staehelin T. Monoclonal antibodies can discriminate between some active and inactive forms of leukocyte interferon. Archives of Biochemistry and Biophysics. 224: 111-6. PMID 6870247 DOI: 10.1016/0003-9861(83)90194-7 |
0.398 |
|
| Show low-probability matches. |